This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Children's National Medical Center. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: The Innovations of Evan P Nadler
Introduction
Evan P Nadler is a notable inventor based in Washington, DC, recognized for his contributions to the field of medical research. He holds 2 patents that focus on the innovative use of exosomes, particularly in relation to obesity-related disorders. His work has significant implications for the detection and treatment of these conditions.
Latest Patents
Nadler's latest patents include groundbreaking inventions related to exosomes. The first patent, titled "Exosomes and methods of use thereof," provides methods for utilizing adipocyte-derived exosomes. The second patent focuses on the isolation of these exosomes from biological samples, along with methods, compositions, and kits designed for detecting and screening obesity-related disorders. This invention aims to identify therapies and therapeutic agents for treating or preventing obesity-related conditions.
Career Highlights
Evan P Nadler is affiliated with the Children's National Medical Center, where he contributes to advancing medical research and innovation. His work is pivotal in understanding the role of exosomes in obesity and related health issues.
Collaborations
Nadler collaborates with esteemed colleagues such as Robert J Freishtat and Monica Hubal, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Evan P Nadler's innovative work in the field of exosomes and obesity-related disorders showcases his commitment to advancing medical science. His patents reflect a significant step forward in the detection and treatment of obesity, highlighting the importance of research in improving health outcomes.